SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-028593
Filing Date
2019-05-10
Accepted
2019-05-10 15:38:41
Documents
84
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-7744_110q.htm 10-Q 1166107
2 EX-31.1 a19-7744_1ex31d1.htm EX-31.1 12361
3 EX-31.2 a19-7744_1ex31d2.htm EX-31.2 12415
4 EX-32.1 a19-7744_1ex32d1.htm EX-32.1 6206
5 EX-32.2 a19-7744_1ex32d2.htm EX-32.2 6232
12 GRAPHIC g77441gai001.gif GRAPHIC 66131
  Complete submission text file 0001104659-19-028593.txt   6719117

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20190331.xml EX-101.INS 1663083
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20190331.xsd EX-101.SCH 55526
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20190331_cal.xml EX-101.CAL 79604
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20190331_def.xml EX-101.DEF 132845
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20190331_lab.xml EX-101.LAB 482181
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20190331_pre.xml EX-101.PRE 324627
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 19814665
SIC: 2834 Pharmaceutical Preparations